Since 2014, our Roche Global Access Program has provided a mechanism to combine our innovation and expertise to establish diagnostics as a backbone for more resilient health systems. By working closely with ministers of health, international agencies, national disease program experts, non-governmental organizations (NGOs), and private sector entities at the global, regional and local levels, we have been transforming lives and health systems in 89 low-and-middle income countries across Africa, Europe, Latin America and Asia.

We leverage our extensive expertise in public health, evidence generation, and diagnostic excellence to:

Changing the stats towards disease elimination goals

Even with available tests and treatment, every three seconds a person dies due to an infectious disease, making it the second leading cause of death worldwide1. It’s estimated that 11 million premature deaths in low-income and middle-income countries could be avoided annually by reducing the diagnostic gap for six priority conditions including HIV, tuberculosis and hepatitis B virus infection.2 Even though preventable, cervical cancer continues to be one of the most common cancers among women worldwide, accounting for nine in ten deaths worldwide occurring in low-and-middle income countries3.

In fact, less than 20% of the population living in low-and-middle income countries has access to basic diagnostics2. By expanding access to reliable and affordable diagnostics and ensuring continuous investment in strengthening diagnostics capacity, we can help clinicians improve health outcomes and support the elimination goals related to preventable and treatable diseases.